Recalls / Class II
Class IID-787-2013
Product
Trimix, compounded by Olympia Pharmacy, Orlando, FL
- Affected lot / code info
- B5015 Exp 8/15/13, C50001 Exp 8/28/13, B5011 Exp 8/1/13, C42215 Exp 6/22/13, A5028 Exp 6/2/13, B5011 Exp 6/1/13, B5020 Exp 6/1/13, B50112 Exp 8/11/13, C4186 Exp 6/18/13, C4158 Exp 6/15/13, C4149 Exp 6/14/13, C4111 Exp 6/11/13, B4124 Exp 8/12/13, B4154 Exp 8/15/13, B4198 Exp 8/19/13, B4226 Exp 8/22/13, B4268 Exp 8/22/13, C40522 Exp 9/5/13, C4118 Exp 9/1/13, C4711 Exp 9/7/13, C41121 Exp 9/11/13, C4126 Exp 9/12/13 and B42715 Exp 8/27/13.
Why it was recalled
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Recalling firm
- Firm
- Lowlite Investments, Inc. D/B/A Olympia Pharmacy
- Notification channel
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
- Type
- Voluntary: Firm initiated
- Address
- 6700 Conroy Windermere Rd, Suite 140, Orlando, Florida 32835-3500
Distribution
- Quantity
- 24
- Distribution pattern
- Nationwide and PR
Timeline
- Recall initiated
- 2013-05-29
- FDA classified
- 2013-07-11
- Posted by FDA
- 2013-07-17
- Status
- Ongoing
Source: openFDA Drug Enforcement endpoint. Recall record D-787-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.